Here's a quandary: You're a good-sized drugmaker, but not a behemoth able to throw your weight around the industry's big trade associations. So how do you get your voice heard in our nation's capital? Form your own association, of course. That's exactly what Celgene [1], Cephalon [2], Cubist [3], Endo [4], Millennium [5], Purdue [6] and Sepracor [7] are doing: Banding together under the name America's Specialty Medicines Companies, and hiring a D.C. law firm for help getting organized.
What might this assortment's key issues be? That's unclear as yet. But you can bet we'll hear more from them as time goes by.
- read the item [8] at In Vivo
Related Articles:
Dems swayed by pharma lobbying push [9]
PhRMA plows $22M into 2007 lobbying [10]
Millennium spent $1.3M on lobbying [11]
Pharma lobbies big-time in '07 [12]
Links:
[1] http://www.fiercebiotech.com/tags/celgene
[2] http://www.fiercepharma.com/tags/cephalon
[3] http://www.fiercebiotech.com/tags/cubist-pharmaceuticals
[4] http://www.fiercebiotech.com/story/endo-pulls-frova-app-after-mulling-fda-response/2008-04-08
[5] http://www.fiercebiotech.com/tags/millennium-pharmaceuticals
[6] http://www.fiercebiotech.com/story/purdue-jumps-ahead-in-pain-drug-race/2008-04-29
[7] http://www.fiercebiotech.com/story/sepracor-inks-47m-ip-licensing-deal-with-arrow/2008-05-01
[8] http://invivoblog.blogspot.com/2008/05/association-of-ones-own-specialty.html
[9] http://www.fiercepharma.com/story/dems-swayed-by-pharma-lobbying-push/2008-03-12
[10] http://www.fiercepharma.com/story/phrma-plows-22m-into-2007-lobbying/2008-02-22
[11] http://www.fiercebiotech.com/story/millennium-spent-1-3m-lobbying/2008-02-08
[12] http://www.fiercepharma.com/story/pharma-lobbies-big-time-07/2007-09-19